Search for Tradename: VYTORIN
Summary for Tradename: VYTORIN
|
|
Latest news for VYTORINReportlinker Adds Cardiovascular Generic Drugs: Prospects and Opportunities to 201231 August 2010, 12:19 pm Merck and high grade bonds beat junk as economy slows30 August 2010, 11:24 am U.S. Stocks Fall for Third Week, Longest Decline Since February28 August 2010, 1:14 am AstraZeneca's Crestor cuts deaths and heart attacks27 August 2010, 6:58 pm Industry news25 August 2010, 8:56 am Merck sues over generic version of Vytorin23 August 2010, 2:25 pm Impax Laboratories Confirms Patent Challenge Relating To VYTORIN(R), 10 Mg/80 Mg23 August 2010, 9:19 am Merck-Impax, Pfizer, Apple, Righthaven, Madonna: Intellectual Property23 August 2010, 1:25 am Impax confirms initiation of challenge of patents listed by MSP Singapore for VYTORIN21 August 2010, 3:19 am Courtesy of Yahoo News |
Glossary
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | RLD | Patent Number | Product | Substance | Delist Req. | Patent Expiration | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msp Singapore | VYTORIN | ezetimibe; simvastatin | 021687 | Jul 23, 2004 | RX | No | Apr 3, 2010 | |||||
| Msp Singapore | VYTORIN | ezetimibe; simvastatin | 021687 | Jul 23, 2004 | RX | No | Dec 5, 2011 | |||||
| Msp Singapore | VYTORIN | ezetimibe; simvastatin | 021687 | Jul 23, 2004 | RX | No | Jun 5, 2011 |
This preview shows a limited data set. Complete access is available with a Subscription
Paragraph IV activity for: VYTORIN
| Drugname | Dosage | Strength | RLD | Submissiondate |
| ezetimibe and simvastatin | Tablets | 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg | Vytorin | 7/27/2009 |
<- Back to Dashboard
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2000-2010, thinkBiotech LLC.
Follow DrugPatentWatch on Twitter![[del.icio.us]](/inc/bookmarkify/delicious.png)
![[Digg]](/inc/bookmarkify/digg.png)
![[Reddit]](/inc/bookmarkify/reddit.png)
![[Facebook]](/inc/bookmarkify/facebook.png)
![[LinkedIn]](/inc/bookmarkify/linkedin.png)
![[StumbleUpon]](/inc/bookmarkify/stumbleupon.png)
![[Technorati]](/inc/bookmarkify/technorati.png)
![[Twitter]](/inc/bookmarkify/twitter.png)
![[Email]](/inc/bookmarkify/email.png)